The Asia Pacific Deep Brain Stimulation Devices Market would witness market growth of 17.6% CAGR during the forecast period (2019-2025). Asia Pacific is projected to see the fastest market growth due to the growing demand in countries like Japan, China and India. The rising disposable income leading to higher spending on healthcare would also support growth in the region. In addition, increasing awareness of various neurological disorders such as epilepsy, critical tremors and Parkinson's disease would fuel Asia Pacific's demand for DBS. Another major factor driving growth in the area is the growing number of medical settings such as specialty clinics and multispecialty hospitals.
During the past 4 decades the field of stereotactic and functional neurosurgery and DBS has expanded rapidly. With advancements in high-resolution imaging, including tractography and functional MRI, identification of individual nuclei or tracts has become more accurate. Such technological advancements also provide guidelines for intraoperative imaging and confirmation of the targets. Technological developments have also been made inside the unit. For standard PD patients the internal pulse generators (IPGs) have a battery life of about 4 years.
Additionally, there are transcutaneous, rechargeable IPGs. With advancements in stimulation programming, multiple options are critical to be able to provide. Today, there's the potential to provide stimulus paradigms interleaving. Modern IPGs can now provide programmed stimulation paradigms as well as store data from leads themselves collected from the electrode. Implanted monitoring systems have opened the way for more neurological disease studies and the underlying electrophysiological changes that arise in these states.
Based on Application, the market is segmented into Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy and Others. Based on End Use, the market is segmented into Diagnostic Centers, Clinics and Hospitals. Based on Applications, the market is segmented into Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder and Other Applications. Based on End User, the market is segmented into Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others. Based on countries, the market is segmented into China, India, Japan, Australia, South Korea, Singapore, and Rest of Asia Pacific.
Free Valuable Insights: Deep Brain Stimulation Devices Market in Asia Pacific is expected to register a CAGR of 17.6% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Functional Neuromodulation, Ltd., Beijing PINS Medical Co., Ltd., NeuroPace, Inc., Nevro Corporation, Neuronetics, Inc., and Fisher Wallace Laboratories, Inc.
Market Segmentation:
By Applications
By End User
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
